secwatch.observer — SEC 8-K summary
======================================

Issuer:     Iris Acquisition Corp (—)
CIK:        0001831874
Form:       8-K
Filed at:   2024-04-05T23:59:59+00:00
Accession:  0001104659-24-044242
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Iris Acquisition Corp extends business combination deadline with Liminatus Pharma to July 31, 2024
--------------------------------------------------------------------------------

- Third amendment to business combination agreement pushes outside date from March 9, 2024 to July 31, 2024.
- PIPE equity and convertible note subscription agreements also extended to July 31, 2024.
- All other terms of the BCA and subscription agreements remain unchanged.
- This is the third extension since the original BCA was signed in November 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1831874/000110465924044242/0001104659-24-044242-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1831874/000110465924044242/tm2411213d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-044242

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer